insights_auto
Why is DNLI up 2.44%?
Dive Deeperchevron_right
DNLI:NASDAQ
Denali Therapeutics Inc
$18.04
arrow_upward
+2.44%(+0.43) 1D
$17.95
arrow_downward
-0.50% (-0.090)bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNLI...
Open
$17.61
High
$18.36
Low
$17.33
Mkt. cap
2.88B
Avg. vol.
1.87M
Volume
2.69M
52-wk high
$27.30
52-wk low
$13.80
EPS
-$2.84
Beta
1.02
Shares outstanding
159.85M
No. of employees
507
Open
$17.61
High
$18.36
Low
$17.33
Mkt. cap
2.88B
Avg. vol.
1.87M
Volume
2.69M
52-wk high
$27.30
52-wk low
$13.80
EPS
-$2.84
Beta
1.02
Shares outstanding
159.85M
No. of employees
507
News stories
From web sources and news partners
www.tokenpost.com
·
1 hour ago
S&P 500's Other 493 Companies Forecast to Outgrow Magnificent Seven in Q4
www.tokenpost.com
·
1 hour ago
SOX-to-S&P 500 Ratio Falls to Lowest Level Since Late April
Crypto Briefing
·
6 hours ago
AI stocks now make up 49% of the S&P 500, the second-highest concentration on record
TradingView
·
6 hours ago
The Dow Jones Index Closes 0.07% Lower
About Denali Therapeutics Inc
CEO-
Employees507
Founded2013
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitedenalitherapeutics.com